Skip to main content
Toggle navigation
Login
Search
Home
Scientific Program
Back
View
Attendees
7
Favorite
Like
Facebook
Tweet
Print
Session: Cellular & Stem Cell Therapeutics
TCR Engineered Tregs for Autoimmune Diseases
Thursday, June 20, 2024
1:40 PM – 2:05 PM
PT
Location: Salon 7
Speaker(s)
Devan Moodley, PhD
Senior Director
Abata Therapeutics
Watertown, Massachusetts, United States
Disclosure(s):
Devan Moodley, PhD
: No financial relationships to disclose
Learning Objectives:
Assess cell therapy landscape for autoimmune diseases
Describe how to engineer Tregs for autoimmune diseases
Distinguish between CARs and TCR engineered Tregs